Table 1 Demographic data of patients with and without ocular symptoms while on dupilumab.
From: Dupilumab-associated ocular surface disease: presentation, management and long-term sequelae
Patients with ocular symptoms while on dupilumab | Patients without ocular symptoms | P value | |
---|---|---|---|
Age ± SD (years) | 38.5 ± 12.1 | 33.5 ± 13.4 | 0.194 |
Gender (F: female, M: male) | 7 F, 7 M | 5 F, 9 M | 0.352 |
Race | 12 Caucasians, 1 of Asian descent, 1 not recorded | 11 Caucasians, 1 of Asian descent, 2 not recorded | 0.355 |